“Pay for Delay”- how off-patent brand name drugs fight off generics
Drug giant Eli Lilly soon faces the loss of patent protection on four out of its top five brand name drugs - accounting for half of annual revenues. Continue reading →
View ArticleBig Pharma’s “Pay for Delay” tactics keep generic drugs off the market
Why drug companies pay hundreds of millions of dollars to competing drug companies for not making drugs. Continue reading →
View ArticleCelebrating the Ethical Nag’s second anniversary!
It's been quite the two-year journey so far here at The Nag, from articles on Big Pharma marketing to PR for the ethically challenged or whistleblowing as a career choice. Find out which posts have...
View Article
More Pages to Explore .....